The effect of topical use of bupivacaine and dexamethasone in tonsilar cavity in order to reduce pain after tonsillectomy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181226042142N1

Enrollment

Registered

2019-03-16

Start date

2019-05-23

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The Effect of Topical Use of Bupivacaine and Dexamethasone in Tonsilar Cavity in order to Reduce Pain After Tonsillectomy. Chronic diseases of tonsils and adenoids

Interventions

Intervention 1: Intervention group: After obtaining informed consent, 30 patients immediately after tonsillectomy place a gas soaked with bupivacaine and dexamethasone into the tonsillar cavity of eac

Eligibility

Sex/Gender

All

Age

2 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with frequent pharyngitis Patients with complaints of chronic bad breath and sore throat Patients with chronic tonsillitis

Exclusion criteria

Exclusion criteria: Coagulation disorders in patients Suspect malignancy Asymmetric of tonsiles

Design outcomes

Primary

Measure	Time frame
Intensity of pain. Timepoint: 12 hours later and 24 hours later and one week after the intervention. Method of measurement: Based on checklist.;Number of nausea and vomiting. Timepoint: 12 hours later and 24 hours later and one week after the intervention. Method of measurement: Based on checklist.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadreza Mohammadi

Arak University of Medical Sciences

www.mm80091@gmail.com+98 86 4633 5314

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026